Tarsus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $58.05 |
Previous Close | $59.31 |
Day Range | $55.52-$59.12 |
52W Range | $38.51-$85.25 |
Market Cap | $2.5B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $535M |
Revenue Growth (YoY) | 106.9% |
Gross Profit (12 Mos) | $427.9M |
Diluted EPS | -$1.11 |
News
See moreYahoo Finance • 3 days ago
Tarsus Pharmaceuticals Enters Retina Market With iRenix Deal, Adds IRX-101 to Pipeline
Yahoo Finance • 6 days ago
Tarsus buys iRenix Medical for $75M, gains late-stage eye care asset IRX-101
Yahoo Finance • 4 months ago
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade
Yahoo Finance • 4 months ago
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
About
CEO | Dr. Bobak R. Azamian M.D. |
Address | 17700 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 370 |